Table 2.
Coverage-adjusted incidence and relative risk of herpes zoster and postherpetic neuralgia by age group and sex
| Group | HZ Adjusted Incidence | HZ RR | PHN Adjusted Incidence | PHN RR |
|---|---|---|---|---|
| Age group | ||||
| 0–9 | 0.16 (0.15–0.17) | Reference | 0.01 (0.01–0.01) | Reference |
| 10–19 | 0.84 (0.82–0.87) | 5.40 (5.03–5.80) | 0.05 (0.05–0.06) | 6.36 (4.67–8.66) |
| 20–29 | 2.51 (2.48–2.56) | 16.16 (15.12–17.27) | 0.15 (0.14–0.16) | 18.93 (14.16–25.32) |
| 30–39 | 4.87 (4.82–4.92) | 31.31 (29.32–33.44) | 0.41 (0.40–0.43) | 50.85 (38.18–67.72) |
| 40–49 | 6.18 (6.12–6.23) | 39.69 (37.17–42.38) | 0.71 (0.69–0.72) | 87.06 (65.42–115.86) |
| 50–59 | 9.68 (9.61–9.74) | 62.17 (58.24–66.37) | 1.24 (1.22–1.27) | 153.36 (115.30–203.98) |
| 60–69 | 15.29 (15.19–15.39) | 98.23 (92.02–104.85) | 2.45 (2.41–2.49) | 301.97 (227.08–401.57) |
| 70–79 | 16.48 (16.35–16.62) | 105.93 (99.21–113.09) | 3.02 (2.97–3.08) | 373.10 (280.51–496.26) |
| ≥80 | 15.94 (15.73–16.15) | 102.41 (95.85–109.43) | 3.19 (3.10–3.28) | 393.65 (295.71–524.02) |
| Sex | ||||
| Male | 6.38 (6.35–6.41) | Reference | 0.90 (0.89–0.92) | Reference |
| Female | 7.24 (7.20–7.27) | 1.13 (1.13–1.14) | 0.98 (0.97–0.99) | 1.09 (1.07–1.10) |
Abbreviations: Values in parentheses are 95% CIs. Incidence is adjusted for RHIP-inclusion coverage